Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3660593011 | Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3660594017 | Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3660595016 | Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3660596015 | A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3660597012 | A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 983171000172118 | leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux agents alkylants | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 899591000172117 | AML (acute myeloïde leukemie) en myelodysplastische syndromen gerelateerd aan een alkylerend middel | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 964121000172115 | acute myeloïde leukemie en myelodysplastische syndromen gerelateerd aan alkylerend middel | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Causative agent | Alkylating agent (substance) | true | Inferred relationship | Some | 1 | |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Associated morphology | acute myeloïde leukemie en myelodysplastisch syndroom bij behandeling met alkylerende stof | false | Inferred relationship | Some | 1 | |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Complication of procedure | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | séquelle | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | After | Administration of antineoplastic agent | true | Inferred relationship | Some | 2 | |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Due to | Administration of antineoplastic agent | true | Inferred relationship | Some | 3 | |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Finding site | Bone marrow structure | true | Inferred relationship | Some | 1 | |
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | affection liée à une drogue et/ou un médicament | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Complication of chemotherapy (disorder) | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Disorder following clinical procedure | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Complication of introduction procedure | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Drug-induced lesion | false | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Is a | Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent | true | Inferred relationship | Some | ||
| Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent | Associated morphology | Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR